Nikole J. Byrne

1.7k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Nikole J. Byrne is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Nikole J. Byrne has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Nikole J. Byrne's work include Cardiovascular Function and Risk Factors (6 papers), Adipose Tissue and Metabolism (4 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Nikole J. Byrne is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Adipose Tissue and Metabolism (4 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Nikole J. Byrne collaborates with scholars based in Canada, United States and United Kingdom. Nikole J. Byrne's co-authors include Jason R.B. Dyck, Jody Levasseur, Grant Masson, Heiko Bugger, Miranda M. Sung, E. Dale Abel, Ty T. Kim, Jamie Boisvenue, Carrie-Lynn M. Soltys and Namakkal S. Rajasekaran and has published in prestigious journals such as Circulation, Circulation Research and Diabetes.

In The Last Decade

Nikole J. Byrne

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin

2021 144 citations Koenraad Philippaert, Subha Kalyaanamoorthy et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nikole J. Byrne Canada	13	548	407	402	271	261	15	1.1k
Jody Levasseur Canada	17	547 1.0×	422 1.0×	504 1.3×	399 1.5×	249 1.0×	21	1.3k
Susana Vallejo Spain	20	381 0.7×	182 0.4×	258 0.6×	244 0.9×	114 0.4×	29	1.2k
Donna L. Beker Canada	13	265 0.5×	167 0.4×	266 0.7×	188 0.7×	133 0.5×	14	650
Flori R. Sari Japan	19	569 1.0×	281 0.7×	291 0.7×	176 0.6×	130 0.5×	32	1.4k
Grant Masson Canada	10	328 0.6×	141 0.3×	190 0.5×	179 0.7×	106 0.4×	12	606
Yunfeng Shen China	17	520 0.9×	387 1.0×	188 0.5×	165 0.6×	202 0.8×	46	1.3k
Guangyao Song China	22	678 1.2×	349 0.9×	141 0.4×	335 1.2×	164 0.6×	107	1.6k
Cecilia Morgantini Canada	18	334 0.6×	587 1.4×	205 0.5×	331 1.2×	443 1.7×	29	1.3k
Erica Vetrano Italy	19	394 0.7×	532 1.3×	348 0.9×	241 0.9×	253 1.0×	34	1.3k
Cristina Campos Carraro Brazil	18	223 0.4×	142 0.3×	291 0.7×	189 0.7×	117 0.4×	61	876

Countries citing papers authored by Nikole J. Byrne

Since Specialization

Citations

This map shows the geographic impact of Nikole J. Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikole J. Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikole J. Byrne more than expected).

Fields of papers citing papers by Nikole J. Byrne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikole J. Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikole J. Byrne. The network helps show where Nikole J. Byrne may publish in the future.

Co-authorship network of co-authors of Nikole J. Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Nikole J. Byrne. A scholar is included among the top collaborators of Nikole J. Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikole J. Byrne. Nikole J. Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gopal, Keshav, Nikole J. Byrne, Bruno Saleme, et al.. (2022). TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure. Science Translational Medicine. 14(669). eabm3565–eabm3565. 18 indexed citations

Bugger, Heiko, Nikole J. Byrne, & E. Dale Abel. (2022). Animal Models of Dysregulated Cardiac Metabolism. Circulation Research. 130(12). 1965–1993. 21 indexed citations

Byrne, Nikole J., Namakkal S. Rajasekaran, E. Dale Abel, & Heiko Bugger. (2021). Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radical Biology and Medicine. 169. 317–342. 119 indexed citations

Gopal, Keshav, Nikole J. Byrne, Bruno Saleme, et al.. (2021). Abstract 9054: Cell-Specific Regulation of the GATA-4/6 Transcription Factors by the Metabolic Enzyme PKM2 Provides Insight into a Biologic Function Essential for Cardiac Health and Survival. Circulation. 144(Suppl_1). 1 indexed citations

Philippaert, Koenraad, Subha Kalyaanamoorthy, Mohammad Fatehi, et al.. (2021). Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin. Circulation. 143(22). 2188–2204. 144 indexed citations breakdown →

Byrne, Nikole J., Nobutoshi Matsumura, Zaid H. Maayah, et al.. (2020). Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure. Circulation Heart Failure. 13(1). e006277–e006277. 177 indexed citations

Byrne, Nikole J., Shubham Soni, Shingo Takahara, et al.. (2020). Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure. Circulation Heart Failure. 13(6). e006573–e006573. 90 indexed citations

Matsumura, Nobutoshi, Shingo Takahara, Zaid H. Maayah, et al.. (2018). Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites. Journal of Molecular and Cellular Cardiology. 125. 162–173. 39 indexed citations

Byrne, Nikole J., Nirmal Parajuli, Jody Levasseur, et al.. (2017). Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure. JACC Basic to Translational Science. 2(4). 347–354. 129 indexed citations

10.

Sung, Miranda M., Nikole J. Byrne, Ian M. Robertson, et al.. (2017). Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 312(4). H842–H853. 68 indexed citations

11.

Sung, Miranda M., Nikole J. Byrne, Ty T. Kim, et al.. (2017). Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 312(3). H552–H560. 41 indexed citations

12.

Byrne, Nikole J., Jody Levasseur, Miranda M. Sung, et al.. (2016). Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression. Cardiovascular Research. 110(2). 249–257. 30 indexed citations

13.

Sung, Miranda M., Ty T. Kim, Emmanuel Denou, et al.. (2016). Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome. Diabetes. 66(2). 418–425. 180 indexed citations

14.

Sung, Miranda M., Nikole J. Byrne, Jody Levasseur, et al.. (2015). Cardiomyocyte‐Specific Ablation of the Long‐Chain Fatty Acid Transporter CD36 Accelerates the Progression of Pressure Overload‐Induced Heart Failure in Mice. The FASEB Journal. 29(S1). 1 indexed citations

15.

Sung, Miranda M., Subhash K. Das, Jody Levasseur, et al.. (2014). Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism. Circulation Heart Failure. 8(1). 128–137. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact